MEDICE receives award for "family friendly company".
Latest News
MEDICE: family friendly company
MEDICE receives award for "family friendly company".
Medikinet retard now in 11 more European countries
Medikinet retard secures a registration expansion in 11 more European countries for the treatment of ADHD in adults
NEW: Alflorex®
NEW within the MEDICE-portfolio: Alflorex® against irritable colon syndrome!
MEDICE in Norway and Denmark
Two new international MEDICE-subsidiaries in Norway and Denmark
New address for your way to MEDICE
Getting to MEDICE: new address!
Business Development Activities During COVID-19
One of the main challenges for 2020 was launching Medikinet Retard in Costa Rica. The official launch event was scheduled and organized for March 2020, when COVID-19 was classified as a global pandemic.
Recommendation champion - Meditonsin takes first place
Meditonsin is THE OTC preparation with the highest customer recommendation rating in Germany.
Helge Braun visiting MEDICE
Helge Braun, Head of the Federal Chancellor's Office, stopped off in Iserlohn on Thursday, 14.08.2020 and visited pharma corporation MEDICE and the Iserlohn local newspaper IKZ.
BAH and BPI throw away historic opportunity
"Revolutionary rethinking in our work environment"
The Pütter family at Medice focus on innovative quality products, with the employee taking centre place.
NEW: Soventol® itch relief spray
the modern alternative for insect bites.
MEDICE opens a subsidiary in Moscow
Pharmaceutical producer from Westphalia takes aim at the Russian market.
MediBee – MEDICE launches its own bee project
In-house honey - since the spring, this has been provided by three bee colonies which have taken up residence on the MEDICE company site.
MEDICE opens its second site in Cologne
Modern office premises in the heart of Cologne give MEDICE employees the opportunity to work near their homes.
Herbal remedy for urinary tract infections
Resistance to antibiotics is advancing around the world and, according to the World Health Organisation, is threatening to destroy decades of research.
New: Medicovid SARS-CoV-2 IgG/IgM rapid antibody test
Medicovid SARS-CoV-2 IgG/IgM rapid test is an EU-licensed, CE-certified in-vitro diagnostic rapid test for the qualitative and semi-quantitative detection of IgM and IgG antibodies against the SARS-CoV-2 coronavirus in human serum or whole blood (obtained via venipuncture). The test combines immunoassay and chromatography and produces a result from venous whole blood within 15 minutes at the point of care with a proven high degree of sensitivity to IgM and IgG of 96.2% and a high level of specificity of 97.9% with the test remaining unresponsive to antibodies of other coronaviruses (HKU1, OC43, NL63, 229E) or chlamydia and mycoplasmas.
New: Medicovid-AG® SARS-CoV-2 rapid antigen test
Iserlohn. With immediate effect, MEDICE markets a SARS-CoV-2 rapid antigen test and so adds to its SARS-CoV-2 rapid test portfolio.
AKTIVADERM® ND - The first skincare treatment with active probiotics for neurodermatitis
Since 1 November 2020, the skin product portfolio of MEDICE has grown to include the innovative medical skincare product AktivaDerm® ND, a skincare treatment with active probiotics for neurodermatitis.
New from MEDICE: STILAXX® COUGH SUPPRESSANT
The specialist herbal treatment for dry irritating coughs.
MEDICE receives special approval for the self-testing of lay persons
The latest generation of Medicovid-AG SARS-CoV-2 Antigen Self-Test, capable of qualitative detection of the specific SARS-CoV-2 antigen through human nasal swabs, is now approved for self-testing.
Medikinet retard secures a registration expansion in 11 more European countries for the treatment of ADHD in adults
NEW within the MEDICE-portfolio: Alflorex® against irritable colon syndrome!
Two new international MEDICE-subsidiaries in Norway and Denmark
Getting to MEDICE: new address!
One of the main challenges for 2020 was launching Medikinet Retard in Costa Rica. The official launch event was scheduled and organized for March 2020, when COVID-19 was classified as a global pandemic.
Meditonsin is THE OTC preparation with the highest customer recommendation rating in Germany.
Helge Braun, Head of the Federal Chancellor's Office, stopped off in Iserlohn on Thursday, 14.08.2020 and visited pharma corporation MEDICE and the Iserlohn local newspaper IKZ.
The Pütter family at Medice focus on innovative quality products, with the employee taking centre place.
the modern alternative for insect bites.
Pharmaceutical producer from Westphalia takes aim at the Russian market.
In-house honey - since the spring, this has been provided by three bee colonies which have taken up residence on the MEDICE company site.
Modern office premises in the heart of Cologne give MEDICE employees the opportunity to work near their homes.
Resistance to antibiotics is advancing around the world and, according to the World Health Organisation, is threatening to destroy decades of research.
Medicovid SARS-CoV-2 IgG/IgM rapid test is an EU-licensed, CE-certified in-vitro diagnostic rapid test for the qualitative and semi-quantitative detection of IgM and IgG antibodies against the SARS-CoV-2 coronavirus in human serum or whole blood (obtained via venipuncture). The test combines immunoassay and chromatography and produces a result from venous whole blood within 15 minutes at the point of care with a proven high degree of sensitivity to IgM and IgG of 96.2% and a high level of specificity of 97.9% with the test remaining unresponsive to antibodies of other coronaviruses (HKU1, OC43, NL63, 229E) or chlamydia and mycoplasmas.
Iserlohn. With immediate effect, MEDICE markets a SARS-CoV-2 rapid antigen test and so adds to its SARS-CoV-2 rapid test portfolio.
Since 1 November 2020, the skin product portfolio of MEDICE has grown to include the innovative medical skincare product AktivaDerm® ND, a skincare treatment with active probiotics for neurodermatitis.
The specialist herbal treatment for dry irritating coughs.
The latest generation of Medicovid-AG SARS-CoV-2 Antigen Self-Test, capable of qualitative detection of the specific SARS-CoV-2 antigen through human nasal swabs, is now approved for self-testing.